<- Go Home

Johnson & Johnson Surgical Vision, Inc.

Johnson & Johnson Surgical Vision, Inc. offers ophthalmic products for cataract and laser refractive surgery. It offers surgical systems that include precision laser system; phacoemulsification systems and accessories including foot pedals, handpieces, and phacoemulsification packs; compact intuitive system; advanced femtosecond laser; excimer laser; advanced wave scan studio system; and StabilEyes capsular tension ring. It also provides ophthalmic viscoelastic devices and intraocular lens that includes multi-focal, toric, and mono-focal lens, and implants. Johnson & Johnson Surgical Vision, Inc. was formerly known as Abbott Medical Optics Inc. and changed its name to Johnson & Johnson Surgical Vision, Inc. in February 2017. The company was founded in 1976 and is based in Jacksonville, Florida. Johnson & Johnson Surgical Vision, Inc. operates as a subsidiary of Johnson & Johnson.

Market Cap

$1.4B

Volume

1.0M

Cash and Equivalents

$50.7M

EBITDA

$269.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$722.2M

Profit Margin

60.94%

52 Week High

$24.90

52 Week Low

$2.88

Dividend

N/A

Price / Book Value

2.12

Price / Earnings

22.66

Price / Tangible Book Value

-1.21

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$154.8M

Return on Equity

9.86%

Return on Assets

3.66

Cash and Short Term Investments

$50.7M

Debt

$1.4B

Equity

$639.6M

Revenue

$1.2B

Unlevered FCF

$172.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches